
AI & The Future of Humanity: Artificial Intelligence, Technology, VR, Algorithm, Automation, ChatBPT, Robotics, Augmented Reality, Big Data, IoT, Social Media, CGI, Generative-AI, Innovation, Nanotechnology, Science, Quantum Computing: The Creative Process Interviews AI, Muse Cells & The Future of Health: Why Stars like Chris Hemsworth & Tony Robbins Turn to Regenerative Medicine
21 snips
Jan 25, 2026 Dr. Adeel Khan, regenerative medicine physician and CEO pioneering Muse cell therapies. He explains how Muse cells home to inflammation, differ from common stem cell treatments, and could reshape care for heart, brain, and autoimmune diseases. Conversation covers a monkey de-aging study, combining cell and gene therapies, and why lifestyle must pair with advanced biologics.
AI Snips
Chapters
Transcript
Episode notes
Cure Triad For Complex Diseases
- Complex diseases like Alzheimer's and type 1 diabetes need multi-pronged approaches beyond single drugs.
- Khan predicts a cure triad of stem cells, gene therapy, and FMT within 5–10 years based on recent studies and trials.
Biological Noise Shows Aging Reversible
- Aging can be measured as 'biological noise' reflecting gene-expression errors across systems.
- After Muse cell infusion, Generation Lab testing showed significant decreases in that static, notably within the immune system.
Monkey Study Shows High Frequency Dosing Reverses Age
- A recent monkey study infused senescent-resistant cells biweekly for a year and reported significant de-aging, illustrating dosing frequency effects.
- Khan contrasts that with Muse dosing, noting annual or semiannual infusions currently due to cost.
